Loading...

Bita Fakhri

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone--
ORCID ORCID Icon0000-0002-2124-7243 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Washington University School of Medicine, St. Louis, MOFellowship2018Hematolgoy and Medical Oncology
    Boston University Medical Canter, Boston, MAResidency2015Internal Medicine
    Washington University School of Medicine, St. Louis, MOGraduate Certificate in Clinical Investigation2018Clinical Investigation
    Yale School of Public Health, New Haven, CTMPH2011Epidemiology and Biostatistics
    Iran University of Medical Sciences, Tehran, IranMD2009Medicine

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse In The News
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide. Ann Diagn Pathol. 2020 May 15; 46:151534. Wen KW, Fakhri B, Menke J, Ruiz-Cordero R, Gill RM, Ohgami RS. PMID: 32473554.
      View in: PubMed   Mentions:    Fields:    
    2. Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy. Clin Cancer Res. 2020 Mar 20. Mato AR, Roeker LE, Jacobs R, Hill BT, Lamanna N, Brander D, Shadman M, Ujjani CS, Yazdy MS, Perini GF, Pinilla-Ibarz JA, Barrientos J, Skarbnik AP, Torka P, Pu JJ, Pagel JM, Gohil S, Fakhri B, Choi M, Coombs CC, Rhodes J, Barr PM, Portell CA, Parry H, Garcia CA, Whitaker KJ, Winter AM, Sitlinger A, Khajavian S, Grajales-Cruz AF, Isaac KM, Shah P, Akhtar OS, Pocock R, Lam K, Voorhees TJ, Schuster SJ, Rodgers TD, Fox CP, Martinez-Calle N, Munir T, Bhavsar EB, Bailey N, Lee JC, Weissbrot HB, Nabhan C, Goodfriend JM, King AC, Zelenetz AD, Dorsey C, Bigelow K, Cheson BD, Allan JN, Eyre TA. PMID: 32198151.
      View in: PubMed   Mentions:    Fields:    
    3. Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series. Clin Lymphoma Myeloma Leuk. 2020 Mar; 20(3):e118-e123. Kambhampati S, Gray L, Fakhri B, Lo M, Vu K, Arora S, Kaplan L, Ai WZ, Andreadis C. PMID: 31948859.
      View in: PubMed   Mentions: 1     Fields:    
    4. CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL. Oncology (Williston Park). 2019 Nov 14; 33(11). Fakhri B, Andreadis C. PMID: 31769861.
      View in: PubMed   Mentions:    Fields:    
    5. Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database. Cancer. 2020 Feb 15; 126(4):808-813. Fakhri B, Fiala MA, Shah N, Vij R, Wildes TM. PMID: 31721140.
      View in: PubMed   Mentions:    Fields:    
    6. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer. 2020 01 15; 126(2):293-303. Ayers EC, Li S, Medeiros LJ, Bond DA, Maddocks KJ, Torka P, Mier Hicks A, Curry M, Wagner-Johnston ND, Karmali R, Behdad A, Fakhri B, Kahl BS, Churnetski MC, Cohen JB, Reddy NM, Modi D, Ramchandren R, Howlett C, Leslie LA, Cytryn S, Diefenbach CS, Faramand R, Chavez JC, Olszewski AJ, Liu Y, Barta SK, Mukhija D, Hill BT, Ma H, Amengual JE, Nathan S, Assouline SE, Orellana-Noia VM, Portell CA, Chandar A, David KA, Giri A, Hess BT, Landsburg DJ. PMID: 31568564.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk. 2019 09; 19(9):e532-e535. Fakhri B, Cashen AF, Duncavage EJ, Watkins MP, Wartman LD, Bartlett NL. PMID: 31279773.
      View in: PubMed   Mentions:    Fields:    
    8. Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma. Br J Haematol. 2019 02; 184(4):524-535. Hill BT, Nastoupil L, Winter AM, Becnel MR, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Fakhri B, Reddy P, Smith SD, Mukhija D, Jagadeesh D, Desai A, Alderuccio JP, Lossos IS, Mehra P, Portell CA, Goldman ML, Calzada O, Cohen JB, Hussain MJ, Ghosh N, Caimi P, Tiutan T, Martin P, Kodali A, Evens AM, Kahl BS. PMID: 30575016.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    9. Bones in Multiple Myeloma: Imaging and Therapy. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:638-646. Zamagni E, Cavo M, Fakhri B, Vij R, Roodman D. PMID: 30231385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies. Clin Lymphoma Myeloma Leuk. 2018 03; 18(3):219-224. Fakhri B, Fiala MA, Tuchman SA, Wildes TM. PMID: 29429818.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Current and emerging treatment options for mantle cell lymphoma. Ther Adv Hematol. 2017 Aug; 8(8):223-234. Fakhri B, Kahl B. PMID: 28811872.
      View in: PubMed   Mentions:
    12. Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature. J Gastrointest Oncol. 2017 Jun; 8(3):379-386. Fakhri B, Lim KH. PMID: 28736626.
      View in: PubMed   Mentions:
    13. Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML. Case Rep Hematol. 2017; 2017:3728429. Fakhri B, Fiala M, Slade M, Westervelt P, Ghobadi A. PMID: 28316846.
      View in: PubMed   Mentions:
    14. Clonal Evolution in Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2016 08; 16 Suppl:S130-4. Fakhri B, Vij R. PMID: 27521309.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Halfway there: the past, present and future of haploidentical transplantation. Bone Marrow Transplant. 2017 Jan; 52(1):1-6. Slade M, Fakhri B, Savani BN, Romee R. PMID: 27454072.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Bita's Networks
    Concepts (35)
    Derived automatically from this person's publications.
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _